Tempo reale
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
3,82 EUR | 0,00% |
|
-1,55% | +6,70% |
Attività
Vendite per attività
CAD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceutical Products, Consumer Health Products and Medical Devices
100,0
%
| 294 | 100,0 % | 328 | 100,0 % | +11,80% |
Vendite per regione
CAD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Brazil
51,3
%
| 135 | 45,9 % | 168 | 51,3 % | +24,86% |
Rest of Latin America
16,8
%
| 40 | 13,7 % | 55 | 16,8 % | +37,17% |
Colombia
13,6
%
| 46 | 15,7 % | 45 | 13,6 % | -3,24% |
Argentina
7,3
%
| 48 | 16,4 % | 24 | 7,3 % | -49,95% |
Canada
6,0
%
| 11 | 3,9 % | 20 | 6,0 % | +73,39% |
Other
5,0
%
| 13 | 4,4 % | 16 | 5,0 % | +26,27% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Samira Sakhia
CEO | Chief Executive Officer | 55 | 01/11/13 |
Jonathan Goodman
FOU | Founder | 56 | 01/11/13 |
Arvind Utchanah
DFI | Director of Finance/CFO | - | 20/06/16 |
Leopoldo Bosano
COO | Chief Operating Officer | - | - |
Monica Percario
CTO | Chief Tech/Sci/R&D Officer | - | - |
Susan Emblem
HRO | Human Resources Officer | - | 01/10/20 |
Amal Khouri
PRN | Corporate Officer/Principal | - | 01/08/14 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
James Gale
BRD | Director/Board Member | 74 | 06/01/14 |
Jonathan Goodman
FOU | Founder | 56 | 01/11/13 |
Robert Lande
BRD | Director/Board Member | 61 | 01/01/13 |
Samira Sakhia
CEO | Chief Executive Officer | 55 | 01/11/13 |
Nicolás Spiguel
BRD | Director/Board Member | 48 | 01/01/20 |
Michael Tremblay
BRD | Director/Board Member | 71 | 01/01/19 |
Janice Murray
BRD | Director/Board Member | 58 | 01/01/20 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 101 327 297 | 55 267 268 ( 54,54 %) | 0 | 54,54 % |
Partecipazioni
Nome | Azioni | % | Valorizzazione |
---|---|---|---|
1 153 897 | 9.45% | 291 936 $ |
Coordinate società
Knight Therapeutics, Inc.
3400 de Maisonneuve West Suite 1055
H3Z 3B8, Montréal
+514-484-4483
http://www.gud-knight.com![Indirizzo Knight Therapeutics Inc.(04K)](https://cdn.zonebourse.com/static/address/154565111.png)
Settore
Vendite per regione
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+6,21% | 70,2 Mrd | |
+30,84% | 10,12 Mrd | |
+29,94% | 4,83 Mrd | |
-20,32% | 4,53 Mrd | |
+14,99% | 3,59 Mrd | |
+20,94% | 2,18 Mrd | |
-39,22% | 1,8 Mrd | |
-44,28% | 1,74 Mrd | |
-0,50% | 1,64 Mrd |
- Borsa valori
- Azioni
- Azione GUD
- Azione 04K
- Società Knight Therapeutics Inc.